Introduction: It is supposed that the serum level of Zinc relates to the cirrhosis. We conducted this study to assess the serum zinc levels in patients with liver cirrhosis. Methods and materials: In this descriptive analytic cohort, 80 patients over 18 years old, mean age 54.23±15.05 with liver cirrhosis referred to Imam Khomeini hospital outpatient's clinic or hospitalized in the internal ward of this hospital in Ahwaz during 2015 were recruited. The severity of the disease based on MELD and Child scoring system, encephalopathy, ascites, SBP, serum zinc levels in patients were measured, and the relationship between these variables and zinc serum level was investigated. Results: The mean serum level was 61.36±25.07, and Zn deficiency observed in 22 patients (27. 5%). Regarding the etiology of cirrhosis, viral hepatitis (B, C) was the most common, followed by cryptogenic, but the Zn serum level was not significantly different considering etiology of the cirrhosis. Moreover, the Zn serum level was not significantly different between groups with different ascites severity and different Child and MELD scoring system, but the difference was significant between groups with or without SBP and encephalopathy. By using regression test, we showed that the correlation of Zn serum level with spontaneous bacterial peritonitis (SBP) and encephalopathy was significant and was not significant with etiology of cirrhosis, ascites and Child and MELD scoring system. Conclusion: We discovered that Zn serum level in cirrhotic patients was lower than normal range (70micg/dl). Moreover, we proved that lower concentration of Zn is correlated with encephalopathy and spontaneous bacterial peritonitis.
INTRODUCTION
Cirrhosis reflects a diffuse process of fibrosis and nodule formation that leads to a reduction of hepatocellular mass, lower function of the liver and alteration of blood flow. Moreover, the activation of hepatic stellate cells increases the amount of collagen and forms other components of extracellular matrix that results in fibrosis. 1 The studies evaluating the prevalence of cirrhosis are rare; however, a study in the United States at tertiary referral centers detected 30,000 cirrhosis cases per year.
2 Furthermore, another study on general population revealed that the number of patients with cirrhosis might be about 400,000 cases. 3 Zinc is an essential trace element in adults, the daily requirement of the zinc is about 10-15 mg, that is absorbed from the upper gastrointestinal tract especially in the small intestine.
4,5 Zinc is essential for the metabolism of nucleic acids and proteins and activates about 300 metalloenzymes in the human body.
6,7 Therefore, zinc deficiency leads to several pathologic conditions, and the studies indicated that the zinc deficiency is related to chronic hepatitis (CH), compensated liver cirrhosis (LC), decompensated LC and hepatocellular carcinoma (HCC).
8-12 A study of 62 patients with chronic hepatitis designated with 300 mg of polaprezinc daily, over three years significantly decreased the AST and ALT levels and the cumulative incidence of HCC.
13
Moreover, some other clinical trials indicated that the Zinc supplementation has a positive effect on the function of the liver.
13-17 Studies evaluating the correlation of zinc with cirrhosis and its complications are rare in Iran, moreover, because of different etiology of cirrhosis between Iranian and western populations, the results of studies conducted in these countries are not in harmony with findings of studies on Iranian people. Therefore, to address these concerns we conducted this study to evaluate the correlation of serum zinc concentration with liver cirrhosis events in patients with cirrhosis that being referred to Imam Khomeini hospital in Ahvaz in southwest of Iran
MATERIALS AND METHODS
In this comparative trial, 80 patients with liver cirrhosis, more than 18 years old that is referred to the outpatient clinics of Imam Khomeini hospital in Ahvaz or patients who were hospitalized in the internal ward of this hospital were recruited. The cirrhosis was confirmed based on the pathologic 
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manifestations evaluation by an internist, and then the severity of diseases was assessed using MELD (Model for End-Stage Liver Disease) and Child (A, B, C) scoring systems. Then an internist evaluated the presence of encephalopathy and spontaneous bacterial peritonitis, and the presence and amount of ascites were assessed by a radiologist and was classified as mild moderate and severe based on the ultrasound findings. Excluding criteria were: age<18, Wilson disease, Zn intake during recent 6 months, consumption of drugs that interact with Zn such as ceftibuten, cephalexin, quinolone antibiotics, tetracycline derivatives, deferiprone, the lack of patients' consent, intake of sedative drugs, the history of brain damage and CVA. The study was explained to all patients and informed written consents were taken. Moreover, the study protocol was approved by the ethic committee of Ahvaz University of Medical Sciences (registration code: IR.AJUMS.REC.1395.45). The enrolled patients were interviewed, and demographic data such as age, sex, history of diuretic intake and smoking were recorded. Then the patients were fully examined, and the presence of ascites, encephalopathy, spontaneous bacterial peritonitis (SBP) was recorded.
Moreover, the blood samples were taken, and the Zn serum level was measured in all patients.
Statistical Analyses
The data were analyzed using Statistical Package for Social Studies version 22.0 (SPSS Inc, Chicago, Ill). Categorical data are presented as numbers (%), and continuous data as mean ± SD. We used the Chai_2 test to compare categorical variables and the Student's t-test to compare continuous variables. The correlation of Zn with other variables was evaluated using regression test. P<0.05 was considered significant.
RESULTS
80 patients including 47 males (58.8%) and 33 females (41.3%), mean age 54.23±15.05 (range,20-85) years old, were studied ( Table 1) . The mean serum level in the patients was 61.36±25.07. Based on the cutoff point of Zn serum level in the normal population, the serum level less than 70 mcg/dl were considered as Zn deficiency that observed in 58 patients (72.5%) ( Table 2 ). The difference of Zn serum level between age and sex groups between patients with or without diuretic consumption was not significant but was significant between patients with and without smoking ( Table 1) . The most common cause of the cirrhosis was viral hepatitis (B, C) followed by cryptogenic, but the Zn serum level was not significantly different regarding etiology of the cirrhosis (Table 3) . Additionally, the Zn serum level was not significantly different between groups with different ascites severity and different Child and MELD scoring system, but the difference was significant between groups with or without SBP and encephalopathy (Table 3) . Using regression test we showed that the correlation of Zn serum level with SBP and encephalopathy was significant and was not significant with etiology of cirrhosis, ascites, and Child, MELD scoring (Table 4) .
DISCUSSION
The fibrosis and cirrhosis formation in the liver is a complex process, and several factors are involved in these process. It is proposed that the Zn serum level relates to division and growth of the cells in the liver. Therefore it may affect the liver mass and liver function. 18 In this cohort study, we evaluated the Zn serum level in 80 patients with cirrhosis and showed the mean of Zn serum level was 61.36±25.07 mcg/dl. This was lower than normal measurements (70 mcg/dl) in healthy population; however, it was more than a study by Kar et al. in India that showed in patients with cirrhosis the level 20, 21 The most common etiology of cirrhosis in current practice was hepatitis B and C. Moreover, the Zn serum level in cirrhotic patients due to NASH and alcohol was lowest and in patients with cholestasis was highest among the patients. However, the amount of Zn was not significantly different between the patients with different causes of cirrhosis. Abbasi et al. supported our results. that did not show a significant difference between Zn serum levels of cirrhotic patients with B or C hepatitis. 22 However, as opposed to our results and Abbasi trial, a study by Gur et al. revealed that the Zn concentration in cirrhotic patients due to B hepatitis was lower than other cirrhotic patients. Moreover, they indicated that Zn in patients with cirrhosis was lower than patients with active chronic hepatitis. 23 Another study by Sengupta et al., in contrary to our findings, confirmed that the Zn serum level in the cirrhotic patients because of alcohol, cholestasis, and C hepatitis was lower than other patients.
24
In present practice, the Zn serum level in patients with encephalopathy was lower than patients without encephalopathy. In conformity with our experience, a study by Rafiei et al. revealed that the Zn concentration in patients with encephalopathy is lower than others. 25 In addition, another study by Sengupta et al. supported these findings and showed lower Zn serum level in patients who were involved in encephalopathy; also, they showed lower Zn serum level in patients with infected ascites and patients with diuretic consumption.
We confirmed these findings and showed lower Zn concentration in patients with SBP, however, the consumption of diuretic in current cohort was not associated with Zn serum level. Harmoniously, studies by Matsuoka 13 and Matsumura, 26 investigated that the lower Zn serum level was related to infection and lower platelet counts, furthermore these studies signified that the higher Zn serum level is associated with better outcomes in patients with cirrhosis. In our practice, the Zn serum level based on Child criteria, results in A class was lower than C class but the difference was not significant, moreover the difference between MELD scores that lower 15 and higher 15 was not significant. Conversely, a study by Schneider et al. detected a significant difference between Child C+B criteria and control group.
21
The correlation of the Zn with several other complications of liver diseases was studied, two studies by Matsumura 26 and Pramoolsinsap
27
revealed that the incidence of hepatocellular carcinoma was correlated to the low level of Zn; also, they specified that Zn decreased the incidence of the hepatocellular carcinoma. Harmoniously, another, study by Iwata et al. revealed a direct association between Zn and esophageal varices and hemorrhage.
28
In current cohort, we did not assess the incidence of hepatocellular carcinoma, moreover did not detect any patients with esophageal hemorrhage. Therefore, more comprehensive studies are needed in this field. Additionally, this was an uncontrolled cohort descriptive. Therefore, we could not compare the level of Zn serum level 
CONCLUSIONS
We revealed that the Zn serum level in patients with cirrhosis is lower than normal range (70mcg/ dl). Likewise, we proved that lower concentration of Zn is correlated with encephalopathy and spontaneous bacterial peritonitis.
